questionsmedicales.fr
Phénomènes génétiques
Structures génétiques
Génome
Génome microbien
Génome viral
Génome viral : Questions médicales fréquentes
Termes MeSH sélectionnés :
Randomized Controlled Trials as Topic
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Génome viral : Questions médicales les plus fréquentes",
"headline": "Génome viral : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Génome viral : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-18",
"dateModified": "2025-04-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Génome viral"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Génome microbien",
"url": "https://questionsmedicales.fr/mesh/D064349",
"about": {
"@type": "MedicalCondition",
"name": "Génome microbien",
"code": {
"@type": "MedicalCode",
"code": "D064349",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gènes viraux",
"alternateName": "Genes, Viral",
"url": "https://questionsmedicales.fr/mesh/D005814",
"about": {
"@type": "MedicalCondition",
"name": "Gènes viraux",
"code": {
"@type": "MedicalCode",
"code": "D005814",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gènes env",
"alternateName": "Genes, env",
"url": "https://questionsmedicales.fr/mesh/D015752",
"about": {
"@type": "MedicalCondition",
"name": "Gènes env",
"code": {
"@type": "MedicalCode",
"code": "D015752",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.172"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes gag",
"alternateName": "Genes, gag",
"url": "https://questionsmedicales.fr/mesh/D015750",
"about": {
"@type": "MedicalCondition",
"name": "Gènes gag",
"code": {
"@type": "MedicalCode",
"code": "D015750",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.258"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes précoces",
"alternateName": "Genes, Immediate-Early",
"url": "https://questionsmedicales.fr/mesh/D017781",
"about": {
"@type": "MedicalCondition",
"name": "Gènes précoces",
"code": {
"@type": "MedicalCode",
"code": "D017781",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.345"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes de particule intracisternale de type A",
"alternateName": "Genes, Intracisternal A-Particle",
"url": "https://questionsmedicales.fr/mesh/D007426",
"about": {
"@type": "MedicalCondition",
"name": "Gènes de particule intracisternale de type A",
"code": {
"@type": "MedicalCode",
"code": "D007426",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.360"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes nef",
"alternateName": "Genes, nef",
"url": "https://questionsmedicales.fr/mesh/D015754",
"about": {
"@type": "MedicalCondition",
"name": "Gènes nef",
"code": {
"@type": "MedicalCode",
"code": "D015754",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes pol",
"alternateName": "Genes, pol",
"url": "https://questionsmedicales.fr/mesh/D015751",
"about": {
"@type": "MedicalCondition",
"name": "Gènes pol",
"code": {
"@type": "MedicalCode",
"code": "D015751",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.667"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes pX",
"alternateName": "Genes, pX",
"url": "https://questionsmedicales.fr/mesh/D016355",
"about": {
"@type": "MedicalCondition",
"name": "Gènes pX",
"code": {
"@type": "MedicalCode",
"code": "D016355",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.735"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes rev",
"alternateName": "Genes, rev",
"url": "https://questionsmedicales.fr/mesh/D015757",
"about": {
"@type": "MedicalCondition",
"name": "Gènes rev",
"code": {
"@type": "MedicalCode",
"code": "D015757",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.775"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes tat",
"alternateName": "Genes, tat",
"url": "https://questionsmedicales.fr/mesh/D015756",
"about": {
"@type": "MedicalCondition",
"name": "Gènes tat",
"code": {
"@type": "MedicalCode",
"code": "D015756",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.850"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes vif",
"alternateName": "Genes, vif",
"url": "https://questionsmedicales.fr/mesh/D016341",
"about": {
"@type": "MedicalCondition",
"name": "Gènes vif",
"code": {
"@type": "MedicalCode",
"code": "D016341",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.890"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes vpr",
"alternateName": "Genes, vpr",
"url": "https://questionsmedicales.fr/mesh/D016334",
"about": {
"@type": "MedicalCondition",
"name": "Gènes vpr",
"code": {
"@type": "MedicalCode",
"code": "D016334",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.897"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes vpu",
"alternateName": "Genes, vpu",
"url": "https://questionsmedicales.fr/mesh/D016338",
"about": {
"@type": "MedicalCondition",
"name": "Gènes vpu",
"code": {
"@type": "MedicalCode",
"code": "D016338",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.900"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Génome viral",
"alternateName": "Genome, Viral",
"code": {
"@type": "MedicalCode",
"code": "D016679",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kiramage Chathuranga",
"url": "https://questionsmedicales.fr/author/Kiramage%20Chathuranga",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Korea."
}
},
{
"@type": "Person",
"name": "Jong-Soo Lee",
"url": "https://questionsmedicales.fr/author/Jong-Soo%20Lee",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Korea. jongsool@cnu.ac.kr."
}
},
{
"@type": "Person",
"name": "Alfred A Antson",
"url": "https://questionsmedicales.fr/author/Alfred%20A%20Antson",
"affiliation": {
"@type": "Organization",
"name": "York Structural Biology Laboratory, Department of Chemistry, University of York, York, UK. fred.antson@york.ac.uk."
}
},
{
"@type": "Person",
"name": "Stephen S-T Yau",
"url": "https://questionsmedicales.fr/author/Stephen%20S-T%20Yau",
"affiliation": {
"@type": "Organization",
"name": "Department of Mathematical Sciences, Tsinghua University, Beijing, 100084, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Anouk Willemsen",
"url": "https://questionsmedicales.fr/author/Anouk%20Willemsen",
"affiliation": {
"@type": "Organization",
"name": "Laboratory MIVEGEC (UMR CNRS IRD University of Montpellier), Centre National de la Recherche Scientifique (CNRS), 911 Avenue Agropolis, BP 64501, 34394 Montpellier cedex 5, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Efficacy on gait and posture control after botulinum toxin A injection for lower-limb spasticity treatment after stroke: A randomized controlled trial.",
"datePublished": "2023-01-16",
"url": "https://questionsmedicales.fr/article/36726851",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fnins.2022.1107688"
}
},
{
"@type": "ScholarlyArticle",
"name": "Application of Propofol Target-Controlled Infusion for Optimized Hemodynamic Status in ESRD Patients Receiving Arteriovenous Access Surgery: A Randomized Controlled Trial.",
"datePublished": "2022-09-01",
"url": "https://questionsmedicales.fr/article/36143879",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/medicina58091203"
}
},
{
"@type": "ScholarlyArticle",
"name": "Randomized trials of PSA screening.",
"datePublished": "2024-06-25",
"url": "https://questionsmedicales.fr/article/38926075",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.urolonc.2024.05.014"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of Efficacy of Pressure Controlled vs. Traditional Manual Mask Ventilation for Newborn Resuscitation - A Simulation-Based Pilot Randomized Control Trial.",
"datePublished": "2023-11-28",
"url": "https://questionsmedicales.fr/article/38012507",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12098-023-04938-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "The effect of acute and 14-day exogenous ketone supplementation on glycaemic control in adults with type 2 diabetes: two randomized controlled trials.",
"datePublished": "2023-11-22",
"url": "https://questionsmedicales.fr/article/37991451",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1152/ajpendo.00332.2023"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Génome",
"item": "https://questionsmedicales.fr/mesh/D016678"
},
{
"@type": "ListItem",
"position": 5,
"name": "Génome microbien",
"item": "https://questionsmedicales.fr/mesh/D064349"
},
{
"@type": "ListItem",
"position": 6,
"name": "Génome viral",
"item": "https://questionsmedicales.fr/mesh/D016679"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Génome viral - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Génome viral",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Génome viral",
"description": "Comment détecte-t-on un génome viral ?\nQuels tests sont utilisés pour le génome viral ?\nPeut-on séquencer un génome viral ?\nQuels symptômes indiquent une infection virale ?\nComment différencier les virus par leur génome ?",
"url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Génome viral",
"description": "Quels sont les symptômes d'une infection virale ?\nLes symptômes varient-ils selon le virus ?\nComment les symptômes évoluent-ils ?\nLes symptômes sont-ils toujours présents ?\nQuels symptômes indiquent une complication ?",
"url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Génome viral",
"description": "Comment prévenir les infections virales ?\nLes vaccins sont-ils efficaces contre tous les virus ?\nQuelles mesures de santé publique aident à prévenir les épidémies ?\nLe port de masque aide-t-il à prévenir les infections ?\nLes voyages augmentent-ils le risque d'infection virale ?",
"url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Génome viral",
"description": "Quels traitements existent pour les infections virales ?\nLes antibiotiques sont-ils efficaces contre les virus ?\nComment les antiviraux agissent-ils ?\nLes traitements varient-ils selon le virus ?\nLes vaccins préviennent-ils toutes les infections virales ?",
"url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Génome viral",
"description": "Quelles sont les complications possibles d'une infection virale ?\nComment les complications sont-elles traitées ?\nLes complications sont-elles fréquentes ?\nLes personnes âgées sont-elles plus à risque de complications ?\nComment prévenir les complications ?",
"url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Génome viral",
"description": "Quels sont les facteurs de risque d'infection virale ?\nLe mode de vie influence-t-il le risque d'infection ?\nLes maladies chroniques augmentent-elles le risque ?\nLes voyages à l'étranger augmentent-ils le risque ?\nLes contacts fréquents avec des malades augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecte-t-on un génome viral ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "On utilise des techniques comme la PCR pour identifier le matériel génétique viral."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le génome viral ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques et les tests moléculaires sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Peut-on séquencer un génome viral ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le séquençage permet d'analyser la structure du génome viral."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection virale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, toux et douleurs musculaires peuvent signaler une infection virale."
}
},
{
"@type": "Question",
"name": "Comment différencier les virus par leur génome ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse du type d'acide nucléique (ADN ou ARN) aide à classer les virus."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, toux, fatigue, et parfois éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut provoquer des symptômes spécifiques selon son type."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver ou s'améliorer selon la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains virus peuvent être asymptomatiques chez certaines personnes."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une complication ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des difficultés respiratoires ou des douleurs thoraciques peuvent signaler des complications."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections virales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains, éviter les contacts étroits et se faire vacciner sont essentiels."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils efficaces contre tous les virus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque vaccin cible des virus spécifiques et n'offre pas une protection universelle."
}
},
{
"@type": "Question",
"name": "Quelles mesures de santé publique aident à prévenir les épidémies ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance épidémiologique et la vaccination de masse sont cruciales."
}
},
{
"@type": "Question",
"name": "Le port de masque aide-t-il à prévenir les infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le port de masque réduit la transmission des virus respiratoires."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection virale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent faciliter la propagation des virus d'une région à une autre."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les infections virales ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux, les traitements symptomatiques et les vaccins sont utilisés."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les virus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales."
}
},
{
"@type": "Question",
"name": "Comment les antiviraux agissent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils inhibent la réplication virale ou bloquent l'entrée du virus dans les cellules."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon le virus ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut nécessiter un traitement spécifique adapté."
}
},
{
"@type": "Question",
"name": "Les vaccins préviennent-ils toutes les infections virales ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins ne couvrent pas tous les virus, mais protègent contre certains."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une infection virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure pneumonie, encéphalite ou défaillance organique."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles traitées ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la complication, souvent avec des soins de soutien."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend du virus et de l'état de santé de l'individu, certaines infections sont plus risquées."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru de complications graves lors d'infections virales."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic précoce et un traitement approprié peuvent réduire le risque de complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'infection virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, l'immunodépression et l'exposition à des personnes infectées."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque d'infections virales."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies chroniques peuvent affaiblir le système immunitaire et augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones à forte incidence de virus peut accroître le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les contacts fréquents avec des malades augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, être en contact étroit avec des personnes infectées augmente le risque d'infection."
}
}
]
}
]
}
└─
Gènes viraux
Genes, Viral
D005814
-
G05.360.340.358.840.500
└─└─
Gènes env
Genes, env
D015752
-
G05.360.340.358.840.500.172
└─└─
Gènes gag
Genes, gag
D015750
-
G05.360.340.358.840.500.258
└─└─
Gènes précoces
Genes, Immediate-Early
D017781
-
G05.360.340.358.840.500.345
└─└─
Gènes de particule intracisternale de type A
Genes, Intracisternal A-Particle
D007426
-
G05.360.340.358.840.500.360
└─└─
Gènes nef
Genes, nef
D015754
-
G05.360.340.358.840.500.600
└─└─
Gènes pol
Genes, pol
D015751
-
G05.360.340.358.840.500.667
└─└─
Gènes pX
Genes, pX
D016355
-
G05.360.340.358.840.500.735
└─└─
Gènes rev
Genes, rev
D015757
-
G05.360.340.358.840.500.775
└─└─
Gènes tat
Genes, tat
D015756
-
G05.360.340.358.840.500.850
└─└─
Gènes vif
Genes, vif
D016341
-
G05.360.340.358.840.500.890
└─└─
Gènes vpr
Genes, vpr
D016334
-
G05.360.340.358.840.500.897
└─└─
Gènes vpu
Genes, vpu
D016338
-
G05.360.340.358.840.500.900
To observe the efficacy of botulinum toxin type A (BoNT-A) for the spasticity of the lower-limb post-stroke on gait and posture control....
A total of 46 patients with hemiplegia gait were randomly divided into the experimental group (23 patients) and the control group (23 patients). In patients in the experimental group received injectio...
At 1, 4, and 12 weeks after treatment, the L-FMA, stride length, speed, and TUGT significantly improved than 0 week in both groups. The L-FMA and peak of forefoot pressure, and MAS results in the expe...
Botulinum toxin type A injection can improve motor functions of the lower limb, gait, spasticity, forefoot pressure, and posture control of patients after stroke....
Background and Objectives: End-stage renal disease (ESRD) is associated with increased anesthetic risks such as cardiovascular events resulting in higher perioperative mortality rates. This study inve...
The role of prostate-specific antigen (PSA) testing in prostate cancer (PCa) screening has evolved over recent decades with multiple randomized controlled trials (RCTs) spurring guideline changes. At ...
We summarize findings from primary RCTs investigating PSA screening's impact on PCa mortality and incidence: the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, the European Ran...
The PLCO Trial randomized men to annual PSA and DRE screening or usual care, reporting no significant difference in PCa mortality between groups at 17 years (RR 0.93, [95% CI: 0.81-1.08]), yet signifi...
While the CAP and initial PLCO trials showed no significant reduction in PCa mortality, the ERSPC demonstrated a 21% reduction at 13 years, with further benefits at extended follow-up. Differences in ...
To determine efficacy of non-invasive positive pressure face mask ventilation using a ventilator device (NIPPmV) for achieving early effective ventilation compared to that by self-inflating bag (SIB) ...
The authors video recorded 33 trained resuscitators using NIPPmV (provided using ventilator device), SIB [a 500 ml silicone SIB without a positive end expiratory pressure (PEEP) valve] and a TPR. Usin...
Total 99 videos were recorded. The time(s) taken to achieve the first chest rise was significantly lesser in NIPPmV group compared to SIB and TPR (3.0 ± 1.7 vs. 3.7 ± 1.9 vs. 7.5 ± 5.4, respectively, ...
The non-invasive positive pressure face mask ventilation using a ventilator (NIPPmV) resulted in achieving early, effective and consistent ventilation....
Acute ingestion of the exogenous ketone monoester supplement [(R)-3-hydroxybutyl-(R)-3-hydroxybutyrate] lowers blood glucose, suggesting therapeutic potential in individuals with impaired glucose meta...
The aim of this study was to assess the efficacy of continuous glucose monitoring (CGM) versus self-monitoring of blood glucose (SMBG) in maintaining glycaemic control among people with type 2 diabete...
The protocol was registered in PROSPERO (CRD42023387583). PubMed, Web of Science, EMBASE and OVID databases were searched from 1 January 2000 until 31 December 2022 for randomized controlled trials co...
Eleven high-quality studies, involving 1425 individuals with T2DM, were identified. Traditional meta-analysis revealed that CGM exhibited a significantly decreased [mean difference (MD): -0.31, 95% co...
CGM could provide T2DM with greater benefits in glycaemic management compared with SMBG, particularly in patients using real-time CGM. These findings provide an updated perspective on previous researc...
To evaluate the effects of core stabilization training on respiratory muscle strength, respiratory functions, and postural control in children with hearing loss....
We conducted a randomized controlled trial at Bezmialem Vakif University, Faculty of Health Sciences, Division of Physiotherapy and Rehabilitation. Thirty children with hearing loss who were diagnosed...
In the study group, a significant improvement was observed in force vital capacity, peak expiratory flow of the spirometry test, maximum inspiratory pressure/expiratory pressure (MEP) of the respirato...
Core stabilization exercises were effective in improving respiratory muscle strength, spirometry, and postural control in children with hearing loss....
Virtual reality (VR) is a promising non-pharmacological pain intervention because it may not only distract but also modulate pain by immersing the user in a three-dimensional 360° alternate reality. I...
Seventy-two children (mean age 10.2 (6-14) years) were randomized to 24 sequences of four interventions (immersive VR Game, immersive VR video, tablet: 2D video and control: small talk). Outcome measu...
PPT increased significantly during VR game (PPTdiff): 136 kPa (CI 112; 161), p < 0.0001 and VR Video (PPTdiff): 122 kPa (CI 91; 153), p < 0.0001. Also, anxiety levels significantly decreased during bo...
VR had a marked beneficial effect on PPT and anxiety compared with the control interventions: 2D video and small talk. Thus, immersive VR had a distinct modulatory effect on pain and anxiety in a well...
Paediatric immersive VR seems to be beneficial although well-controlled studies are pending. We investigated whether immersive VR can modulate children's threshold for pain and anxiety level in an exp...
Nursing homes in the United States were devastated by COVID-19, with 710,000 cases and 138,000 deaths nationally through October 2021. Although facilities are required to have infection control staff,...
Our study seeks to answer the research question of how evidence-based infection control guidelines can be implemented effectively in nursing homes, including comparing the effectiveness of two ECHO-de...
A stratified cluster randomized design was utilized. Using a 1:1 ratio, we randomly assigned 136 nursing homes to ECHO or ECHO Plus arms. Randomization was stratified by geographic location, baseline ...
A total of 290 nursing home facilities were assessed for eligibility, with 136 nursing homes recruited and randomly assigned to ECHO or ECHO Plus. Guided by the Reach, Effectiveness, Adoption, Impleme...
A multipronged approach to improving infection control and emergency preparedness in nursing homes is important, given the toll that the COVID-19 pandemic has taken on residents and staff. The ECHO mo...
ClinicalTrials.gov NCT04499391; https://clinicaltrials.gov/ct2/show/NCT04499391....
Obtaining level 1 evidence on efficacy of glycosaminoglycan (GAG) therapy is difficult, due to low incidence of bladder pain syndrome/interstitial cystitis (BPS/IC) and heterogeneous symptoms experien...
The GETSBI study is a double-blind multidesign multicentre randomised placebo-controlled study to assess the short-term and long-term efficacy of hyaluronic acid (1.6%) + chondroitin sulfate (2%) ther...
Ethical approval was given by METC Oost-Nederland, file number: 2020-7265, NL-number: NL76290.091.20. Findings from this study will be disseminated via publication, reports and conference presentation...
ClinicalTrials.gov identifier (NCT number): NCT05518864....